AR115304A1 - Células madre / progenitoras de las glándulas de brunner duodenales y métodos para su aislamiento y uso - Google Patents
Células madre / progenitoras de las glándulas de brunner duodenales y métodos para su aislamiento y usoInfo
- Publication number
- AR115304A1 AR115304A1 ARP190100808A ARP190100808A AR115304A1 AR 115304 A1 AR115304 A1 AR 115304A1 AR P190100808 A ARP190100808 A AR P190100808A AR P190100808 A ARP190100808 A AR P190100808A AR 115304 A1 AR115304 A1 AR 115304A1
- Authority
- AR
- Argentina
- Prior art keywords
- stem
- methods
- progenitor cells
- isolation
- cells
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 5
- 210000000465 brunner gland Anatomy 0.000 title abstract 2
- 238000002955 isolation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002183 duodenal effect Effects 0.000 title 1
- 210000001198 duodenum Anatomy 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
- C12N5/068—Stem cells; Progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862650208P | 2018-03-29 | 2018-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR115304A1 true AR115304A1 (es) | 2020-12-23 |
Family
ID=68054860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190100808A AR115304A1 (es) | 2018-03-29 | 2019-03-28 | Células madre / progenitoras de las glándulas de brunner duodenales y métodos para su aislamiento y uso |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20190300849A1 (enExample) |
| EP (1) | EP3781181A4 (enExample) |
| JP (2) | JP7562416B2 (enExample) |
| KR (1) | KR20200140836A (enExample) |
| CN (1) | CN112272698A (enExample) |
| AR (1) | AR115304A1 (enExample) |
| AU (1) | AU2019242887A1 (enExample) |
| BR (1) | BR112020019773A2 (enExample) |
| CA (1) | CA3112650A1 (enExample) |
| IL (2) | IL311366B2 (enExample) |
| MX (1) | MX2020010223A (enExample) |
| PH (1) | PH12020551584A1 (enExample) |
| SG (1) | SG11202009428YA (enExample) |
| TW (1) | TW202002997A (enExample) |
| WO (1) | WO2019191402A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202104575WA (en) | 2016-11-04 | 2021-06-29 | Childrens Hospital Med Ct | Liver organoid compositions and methods of making and using same |
| CA3106634A1 (en) | 2018-07-26 | 2020-01-30 | Children's Hospital Medical Center | Hepato-biliary-pancreatic tissues and methods of making same |
| CN112823012A (zh) | 2018-09-12 | 2021-05-18 | 儿童医院医学中心 | 用于产生造血干细胞及其衍生物的类器官组合物 |
| WO2020160371A1 (en) | 2019-02-01 | 2020-08-06 | The University Of Hong Kong | Innervated organoid compositions and methods of making same |
| CA3141807A1 (en) | 2019-05-31 | 2020-12-03 | Children's Hospital Medical Center | Methods of generating and expanding hematopoietic stem cells |
| US12534709B2 (en) | 2019-05-31 | 2026-01-27 | Children's Hospital Medical Center | Shaped organoid compositions and methods of making same |
| KR102322635B1 (ko) * | 2021-06-11 | 2021-11-05 | 인제대학교 산학협력단 | 말초신경양 미세조직 제조방법 및 이의 용도 |
| AU2022304681A1 (en) * | 2021-07-02 | 2024-01-25 | Children’S Hospital Medical Center | Structurally complete organoids |
| WO2023171702A1 (ja) * | 2022-03-08 | 2023-09-14 | 慶應義塾 | オルガノイドの製造方法 |
| KR20250118284A (ko) * | 2024-01-29 | 2025-08-06 | (의) 삼성의료재단 | 중간엽 줄기세포 유래 췌도 오가노이드의 제조방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002057430A2 (en) * | 2001-01-20 | 2002-07-25 | Cardion Ag | Pluripotent adult stem cells derived from regenerative tissue |
| US20050256077A1 (en) | 2004-03-30 | 2005-11-17 | Henning Susan J | Gastrointestinal stem cells and uses thereof |
| US20070026520A1 (en) * | 2005-07-29 | 2007-02-01 | Kelly James H | Novel cells, compositions, and methods |
| US20070128584A1 (en) | 2005-12-01 | 2007-06-07 | Illani Atwater | Method for isolation of cells |
| CN101668848B (zh) * | 2007-04-26 | 2014-10-22 | 雷蒙特亚特特拉维夫大学有限公司 | 来自口腔粘膜的多能自体干细胞和使用方法 |
| US20090269769A1 (en) | 2008-04-23 | 2009-10-29 | Asit Panja | Drug Discovery Methods Involving A Preclinical, In Vitro Isolated Gastrointestinal Epithelial Stem Cell-Like Progenitor Cell System |
| EP2326336B1 (en) * | 2008-07-30 | 2015-05-13 | Mesynthes Limited | Tissue scaffolds derived from forestomach extracellular matrix |
| US8895300B2 (en) * | 2008-11-04 | 2014-11-25 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
| US8367316B2 (en) * | 2009-05-01 | 2013-02-05 | Alfagene Bioscience, Inc. | Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof |
| ES2819028T3 (es) * | 2009-10-30 | 2021-04-14 | Univ North Carolina Chapel Hill | Células madre multipotentes del árbol biliar extrahepático y métodos para su aislamiento |
| WO2012070014A2 (en) * | 2010-11-26 | 2012-05-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells |
| US9533013B2 (en) * | 2013-03-13 | 2017-01-03 | University Of North Carolina At Chapel Hill | Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree |
| CN105087479A (zh) * | 2015-08-21 | 2015-11-25 | 深圳爱生再生医学科技有限公司 | 干细胞无血清培养基及干细胞的培养方法 |
-
2019
- 2019-03-28 CA CA3112650A patent/CA3112650A1/en active Pending
- 2019-03-28 JP JP2020552401A patent/JP7562416B2/ja active Active
- 2019-03-28 TW TW108111024A patent/TW202002997A/zh unknown
- 2019-03-28 AR ARP190100808A patent/AR115304A1/es unknown
- 2019-03-28 US US16/368,524 patent/US20190300849A1/en active Pending
- 2019-03-28 MX MX2020010223A patent/MX2020010223A/es unknown
- 2019-03-28 IL IL311366A patent/IL311366B2/en unknown
- 2019-03-28 BR BR112020019773-4A patent/BR112020019773A2/pt not_active IP Right Cessation
- 2019-03-28 KR KR1020207030724A patent/KR20200140836A/ko not_active Ceased
- 2019-03-28 CN CN201980033560.8A patent/CN112272698A/zh active Pending
- 2019-03-28 IL IL277552A patent/IL277552B2/en unknown
- 2019-03-28 SG SG11202009428YA patent/SG11202009428YA/en unknown
- 2019-03-28 EP EP19774805.6A patent/EP3781181A4/en not_active Withdrawn
- 2019-03-28 WO PCT/US2019/024543 patent/WO2019191402A1/en not_active Ceased
- 2019-03-28 AU AU2019242887A patent/AU2019242887A1/en not_active Abandoned
-
2020
- 2020-09-28 PH PH12020551584A patent/PH12020551584A1/en unknown
-
2024
- 2024-03-21 JP JP2024044463A patent/JP2024075687A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020019773A2 (pt) | 2021-02-17 |
| CA3112650A1 (en) | 2019-10-03 |
| IL277552B1 (en) | 2024-04-01 |
| IL311366B1 (en) | 2025-01-01 |
| SG11202009428YA (en) | 2020-10-29 |
| MX2020010223A (es) | 2021-01-15 |
| KR20200140836A (ko) | 2020-12-16 |
| IL277552B2 (en) | 2024-08-01 |
| JP7562416B2 (ja) | 2024-10-07 |
| EP3781181A1 (en) | 2021-02-24 |
| JP2021519585A (ja) | 2021-08-12 |
| IL311366B2 (en) | 2025-05-01 |
| JP2024075687A (ja) | 2024-06-04 |
| EP3781181A4 (en) | 2021-12-29 |
| IL277552A (en) | 2020-11-30 |
| US20190300849A1 (en) | 2019-10-03 |
| AU2019242887A1 (en) | 2020-11-12 |
| PH12020551584A1 (en) | 2021-09-13 |
| CN112272698A (zh) | 2021-01-26 |
| IL311366A (en) | 2024-05-01 |
| WO2019191402A1 (en) | 2019-10-03 |
| TW202002997A (zh) | 2020-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551584A1 (en) | Stem/progenitor cells from duodenal brunner's glands and methods of isolating and using them | |
| Yang et al. | Regulatory T cells inhibit microglia activation and protect against inflammatory injury in intracerebral hemorrhage | |
| MX2021005155A (es) | Anticuerpo biespecífico y uso del mismo. | |
| PE20200484A1 (es) | Tratamiento para el asma con anticuerpo anti-tslp | |
| NI201100083A (es) | Compuestos que expanden células madre hematopoyéticas. | |
| AR110645A1 (es) | Anticuerpos anti-hla-g y uso de los mismos | |
| MX2020010946A (es) | Anticuerpos multiespecificos y usos del mismo. | |
| BR112015017174A2 (pt) | preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico | |
| MX2020010881A (es) | Construcciones de anticuerpos anti-ror. | |
| SG10201808258SA (en) | Improved methods for manufacturing adoptive cell therapies | |
| CL2019002641A1 (es) | Composiciones y métodos que involucran moléculas probióticas. | |
| ECSP21052194A (es) | Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp | |
| MX2018004546A (es) | Composiciones y métodos para la inhibicion de antígenos específicos de linaje. | |
| AR094375A1 (es) | Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular | |
| BR112021019349A2 (pt) | Células-tronco preparadas altamente funcionais | |
| MX2022003039A (es) | Metodo de seleccion de donantes universales para identificar donantes de celulas nk. | |
| DOP2021000145A (es) | Tratamiento de cefalea por uso excesivo de medicamentos usando anticuerpos anti-cgrp o anti-cgrp-r | |
| MX2019008872A (es) | Prevencion y tratamiento de da?o o enfermedad osea y cartilago. | |
| BR112019001923A2 (pt) | moduladores de nmda de espiro-lactama e métodos de sua utilização | |
| CO2023001681A2 (es) | Bancos de células t específicas para antígeno universal y métodos para producir y usar los mismos terapéuticamente | |
| CL2017000670A1 (es) | Método y composición para producir agentes regenerativos anti-inflamatorios/anti-catabólicos mejorados a partir de fluido fisiológico autólogo | |
| MX2021014961A (es) | Compuestos triciclicos y su uso. | |
| MX2020002085A (es) | Vesiculas extracelulares derivadas de celulas madre/estromales mesenquimaticas. | |
| PY2160662A (es) | Anticuerpos anti-abeta | |
| MX2020004063A (es) | Sistemas y metodos para producir celulas b modificadas geneticamente para expresar anticuerpos seleccionados. |